Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: FASEB J. 2019 Dec 23;34(2):2497–2510. doi: 10.1096/fj.201900897R

Figure 6: PKCδ inhibition improves survival in sepsis.

Figure 6:

Survival was measured for 4 days in septic rats receiving antibiotics (Imipenem-Cilastatin Sodium-25mg/kg) and fluid resuscitation. Septic rats received either a single dose of vehicle (PBS) or PKCδ inhibitor following CLP surgery. Data are shown in a Kaplan-Meier survival plot of study groups. (*p < 0.05; CLP+ vehicle vs CLP +PKCδ inhibitor, n=20 rats/group).